Trends in all‐cause mortality and inpatient and outpatient visits for ambulatory care sensitive conditions during the first year of the COVID‐19 pandemic: A population‐based study
Tetyana Kendzerska(University of Ottawa), Andrea S. Gershon(University of Toronto), Marcus Povitz(University of Calgary), Teresa To(M S Swaminathan Research Foundation), Mohsen Sadatsafavi(University of British Columbia), Michael Pugliese(University of Ottawa), Douglas G. Manuel(University of Ottawa), Melanie Chin(Reata Pharmaceuticals (United States)), Shawn D. Aaron(Ottawa Hospital), Kednapa Thavorn(University of Ottawa), Rébecca Robillard(University of Ottawa), Sunita Mulpuru(University of Ottawa), Claire Kendall(University of Ottawa), Thérèse A. Stukel(University of Toronto), David T. Zhu(Virginia Commonwealth University)
Cited by 21
Related Papers
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
It's about time: A comparison of Canadian and American time–activity patterns
|Journal of Exposure Science & Environmental Epidemiology|2002|699
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
|Canadian Respiratory Journal|2007|685
Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases
|COPD Journal of Chronic Obstructive Pulmonary Disease|2009|664